These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 29927585)

  • 21. Class IB antiarrhythmic drugs: tocainide, mexiletine, and moricizine.
    Snyder DW
    J La State Med Soc; 1989 May; 141(5):21-5. PubMed ID: 2499645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Méxiletine. Action on heart rhythm disorders].
    Lellouche D; Bougherbal R
    Nouv Presse Med; 1975 Feb; 4(5):351-2. PubMed ID: 1093125
    [No Abstract]   [Full Text] [Related]  

  • 23. Hindered disulfide bonds to regulate release rate of model drug from mesoporous silica.
    Nadrah P; Maver U; Jemec A; Tišler T; Bele M; Dražić G; Benčina M; Pintar A; Planinšek O; Gaberšček M
    ACS Appl Mater Interfaces; 2013 May; 5(9):3908-15. PubMed ID: 23581883
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NIR-triggered drug release from switchable rotaxane-functionalized silica-covered Au nanorods.
    Li M; Yan H; Teh C; Korzh V; Zhao Y
    Chem Commun (Camb); 2014 Sep; 50(68):9745-8. PubMed ID: 25019373
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of pharmacokinetic interaction between mexiletine and omeprazole.
    Kusumoto M; Ueno K; Tanaka K; Takeda K; Mashimo K; Kameda T; Fujimura Y; Shibakawa M
    Ann Pharmacother; 1998 Feb; 32(2):182-4. PubMed ID: 9496401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pharmacokinetics and relative bioavailability of a new oral sustained-release form of mexiletine in healthy subjects].
    Santoni Y; Bruno R; Fornaris M; Egre A; Danays T; Cano JP
    Therapie; 1983; 38(4):341-4. PubMed ID: 6648880
    [No Abstract]   [Full Text] [Related]  

  • 27. pH-responsive dendritic core-multishell nanocarriers.
    Fleige E; Achazi K; Schaletzki K; Triemer T; Haag R
    J Control Release; 2014 Jul; 185():99-108. PubMed ID: 24768791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Evaluation of preincisional mexiletine administration to alleviate postoperative pain].
    Morita H; Higashizawa T; Yuasa H; Hiramatsu K; Koga Y
    Masui; 1998 Nov; 47(11):1311-4. PubMed ID: 9852693
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanistic Evaluation of Bioorthogonal Decaging with trans-Cyclooctene: The Effect of Fluorine Substituents on Aryl Azide Reactivity and Decaging from the 1,2,3-Triazoline.
    Matikonda SS; Fairhall JM; Fiedler F; Sanhajariya S; Tucker RAJ; Hook S; Garden AL; Gamble AB
    Bioconjug Chem; 2018 Feb; 29(2):324-334. PubMed ID: 29327914
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor-targeted drug carriers and their enhanced intracellular delivery by pH-sensitivity.
    Zhang K; Yang W; Wang D; Liu C; Qi L; Wang Y
    J Control Release; 2011 Nov; 152 Suppl 1():e95-7. PubMed ID: 22195954
    [No Abstract]   [Full Text] [Related]  

  • 31. [Pharmacokinetics and pharmacodynamics of class I antiarrhythmic agents after a single oral administration].
    Yokota M; Toyama J; Ukai M; Miyahara T; Koide M; Kato R; Yasui S; Sotobata I
    Jpn Circ J; 1992; 56 Suppl 5():1480-4. PubMed ID: 1291746
    [No Abstract]   [Full Text] [Related]  

  • 32. Inverse electron demand Diels-Alder reactions in chemical biology.
    Oliveira BL; Guo Z; Bernardes GJL
    Chem Soc Rev; 2017 Aug; 46(16):4895-4950. PubMed ID: 28660957
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Experience in using anti-arrhythmia preparations of groups I and III in patients with arrhythmia resistant to therapy].
    Abdalla A; Mazur NA
    Kardiologiia; 1988 Mar; 28(3):51-4. PubMed ID: 2454343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dual turn-on fluorescence signal-based controlled release system for real-time monitoring of drug release dynamics in living cells and tumor tissues.
    Kong X; Dong B; Song X; Wang C; Zhang N; Lin W
    Theranostics; 2018; 8(3):800-811. PubMed ID: 29344307
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New Red-Emitting Tetrazine-Phenoxazine Fluorogenic Labels for Live-Cell Intracellular Bioorthogonal Labeling Schemes.
    Knorr G; Kozma E; Herner A; Lemke EA; Kele P
    Chemistry; 2016 Jun; 22(26):8972-9. PubMed ID: 27218228
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The anti-arrhythmic efficacy of perhexiline maleate, disopyramide and mexiletine in ventricular ectopic activity.
    Myburgh DP; Goldman AP
    S Afr Med J; 1978 Dec; 54(25):1053-5. PubMed ID: 371028
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Taste masking of azithromycin by resin complex and sustained release through interpenetrating polymer network with functionalized biopolymers.
    Rajesh AM; Popat KM
    Drug Dev Ind Pharm; 2017 May; 43(5):732-741. PubMed ID: 27600608
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [HPLC-fluorescent spectrometric determination of serum mexiletine concentration after derivatization with fluram].
    Zhang H; Yu C; Liu GY; Jia JY; Hong YC; Xu XR
    Yao Xue Xue Bao; 2003 Mar; 38(3):215-7. PubMed ID: 12830720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of metoprolol tartrate-loaded sustained-release pellets: effect of talc on the mechanism of drug release.
    Wang Y; Yang M; Shen R; Shao S; Chen L; Gong W; Shan L; Gao C
    Pharm Dev Technol; 2018 Sep; 23(7):664-673. PubMed ID: 27470125
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spinal blockades of class I antiarrythmic drugs with bupivacaine by isobolographic analysis in rats.
    Chen YW; Chu CC; Chen YC; Leung YM; Wang JJ
    Neurosci Lett; 2012 Oct; 528(1):46-50. PubMed ID: 22985507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.